Clinical Study

Comparison of Echocardiographic and Electrocardiographic Mapping for Cardiac Resynchronisation Therapy Optimisation

Table 3

Ventricular activation times acquired under the different AVD values tested.

AVD (ms)VaT10-90 index (ms)TVaT (ms)

20081 ± 21139 ± 24
18069 ± 21136 ± 24
16073 ± 21141 ± 23
14068 ± 19141 ± 30
13066 ± 21133 ± 29
12065 ± 21135 ± 29
11067 ± 23138 ± 29
10062 ± 20135 ± 30
8064 ± 18141 ± 24
6067 ± 19147 ± 26
AVD echo-optimal (ms)62 ± 27139 ± 37
AVD ECM optimal (ms)49 ± 24111 ± 23

Values represent means ± SD. AVD, atrioventricular delay; echo, echocardiographic mapping; ECM, electrocardiographic mapping; TVaT, total ventricular activation Time; VaT10-90, ventricular activation time10-90. Values were compared by ANOVA and the Kruskal–Wallis test. No between-group comparisons were significant (Tukey’s HSD).